Physician profile
Ellen E Hampsten
NPI 1821259243
$969.84
in general payments reported to CMS, 2019-2025
16 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $15.71 · 2021: $164 · 2022: $265 · 2023: $153 · 2024: $132 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $221.00 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $118.36 | 2021 | |
| Pfizer INC. | $110.98 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $94.31 | 2019-2024 | Xarelto |
| Teva Pharmaceuticals USA, INC. | $79.44 | 2021-2022 | |
| Astellas Pharma US INC | $72.02 | 2019-2023 | Veozah |
| Dexcom, INC. | $61.06 | 2023-2025 | Dexcom G6 Transmitter |
| Vapotherm INC | $37.73 | 2022-2023 | Vapotherm |
| Lilly USA, LLC | $30.93 | 2023-2024 | Zepbound, Emgality, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.75 | 2025 | Jardiance |
| Sanofi Pasteur INC. | $23.15 | 2019 | |
| Merck Sharp & Dohme LLC | $22.81 | 2025 | Gardasil 9, Capvaxive |
| Arbor Pharmaceuticals, INC. | $22.33 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.35 | 2022 | |
| Xeris Pharmaceuticals, INC. | $14.39 | 2024 | Keveyis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Circassia INC. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Hampsten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.